RCA
CELG

Rowland Carmichael Advisors’s Celgene Corp CELG Stock Holding History

Rowland Carmichael Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,794
Closed -$435K – 348
2018
Q4 		$435K Hold
6,794
– – 0.19% 131
2018
Q3 		$608K Hold
6,794
– – 0.24% 112
2018
Q2 		$540K Sell
6,794
-230
-3% -$19.1K 0.23% 112
2018
Q1 		$627K Hold
7,024
– – 0.34% 94
2017
Q4 		$733K Buy
7,024
+1,477
+27% +$167K 0.38% 86
2017
Q3 		$809K Buy
5,547
+348
+7% +$47.4K 0.45% 67
2017
Q2 		$675K Sell
5,199
-3,573
-41% -$438K 0.39% 84
2017
Q1 		$1.09M Sell
8,772
-1,323
-13% -$158K 0.66% 30
2016
Q4 		$1.17M Sell
10,095
-26
-0.3% -$2.9K 0.69% 31
2016
Q3 		$1.06M Hold
10,121
– – 0.68% 47
2016
Q2 		$998K Buy
10,121
+6,719
+198% +$695K 0.63% 46
2016
Q1 		$341K Buy
+3,402
New +$350K 0.31% 102

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rowland Carmichael Advisors's CELG Position: Q1 2019 in Review

Rowland Carmichael Advisors sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 6,794 shares — an estimated $435K sold.

Rowland Carmichael Advisors first reported a position in CELG in Q1 2016 and held it in 12 quarters. The position peaked at $1.17M in Q4 2016. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Rowland Carmichael Advisors reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Rowland Carmichael Advisors sold 6,794 Celgene Corp shares in Q1 2019, an estimated $435K.
  • Rowland Carmichael Advisors first reported a position in Celgene Corp in Q1 2016 and held it in 12 quarters.
  • Rowland Carmichael Advisors's Celgene Corp position peaked at $1.17M in Q4 2016.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Rowland Carmichael Advisors's 13F filing for Q1 2019, filed 10 Feb 2020.